Encompass Health Raises 2026 Adjusted EPS Outlook to $6.23-$6.37
Bitget2026/10/28 21:09- Encompass Health raised its 2026 adjusted EPS forecast to $6.23-$6.37 from $6.02-$6.25 as of October 28, 2026.
- Net operating revenue guidance increased to $6.45-$6.5 billion from $6.41-$6.49 billion.
- Adjusted EBITDA is now projected at $1.4-$1.42 billion, previously $1.37-$1.4 billion.
- Third-quarter adjusted EBITDA rose 15.5% to $346.6 million; revenue increased 8.9% to $1.61 billion.
- Fourth-quarter assumptions include approximately 2.3% Medicare pricing growth, with bad debt reserves at 2%-2.5% of revenue.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote
Crypto prices
More
